Kercheville Advisors, LLC Abb Vie Inc. Transaction History

Kercheville Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$159.82 - $182.1 $1.1 Million - $1.26 Million	6,900 New	6,900 $1.26 Million
Q2 2022 Jul 18, 2022	SELL	$137.62 - $174.96 $904,163 - $1.15 Million	-6,570 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$131.98 - $163.75 $118,781 - $147,375	-900 Reduced 12.05%	6,570 $1.07 Million
Q4 2021 Jan 26, 2022	BUY	$107.43 - $135.93 $802,502 - $1.02 Million	7,470 New	7,470 $1.01 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Kercheville Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Kercheville Advisors, LLC with notifications on news.